SWIFTBIO CONSULTING LTD
Executive Summary
SWIFTBIO CONSULTING LTD is currently experiencing liquidity challenges and a significant decline in equity, indicative of financial stress despite asset growth. Immediate steps to strengthen working capital, manage costs, and formalise director funding are crucial to restore financial health and ensure sustainable operations.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 11/06/2511 June 2025 | Micro company accounts made up to 2024-09-30 |
| 30/09/2430 September 2024 | Annual accounts for year ending 30 Sep 2024 |
| 25/09/2425 September 2024 | Confirmation statement made on 2024-09-14 with no updates |
| 25/06/2425 June 2024 | Micro company accounts made up to 2023-09-30 |
| 30/09/2330 September 2023 | Annual accounts for year ending 30 Sep 2023 |
| 27/09/2327 September 2023 | Confirmation statement made on 2023-09-14 with no updates |
| 28/04/2328 April 2023 | Micro company accounts made up to 2022-09-30 |
| 30/09/2230 September 2022 | Annual accounts for year ending 30 Sep 2022 |
| 15/09/2215 September 2022 | Confirmation statement made on 2022-09-14 with no updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company